Daniel P. Teufel

1.1k total citations
17 papers, 853 citations indexed

About

Daniel P. Teufel is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel P. Teufel has authored 17 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel P. Teufel's work include Cancer-related Molecular Pathways (6 papers), Protein Structure and Dynamics (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Daniel P. Teufel is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Protein Structure and Dynamics (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Daniel P. Teufel collaborates with scholars based in United Kingdom, Germany and Switzerland. Daniel P. Teufel's co-authors include Mark Bycroft, Stefan M.V. Freund, Alan R. Fersht, A.R. Fersht, Alan R. Fersht, Hannes Neuweiler, C. Mark Johnson, Gavin Bennett, Silvia Pavan and Catherine Stace and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Daniel P. Teufel

17 papers receiving 828 citations

Peers

Countries citing papers authored by Daniel P. Teufel

Since Specialization

Citations

This map shows the geographic impact of Daniel P. Teufel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Teufel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Teufel more than expected).

Fields of papers citing papers by Daniel P. Teufel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Teufel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Teufel. The network helps show where Daniel P. Teufel may publish in the future.

Co-authorship network of co-authors of Daniel P. Teufel

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. Teufel. A scholar is included among the top collaborators of Daniel P. Teufel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. Teufel. Daniel P. Teufel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Molecular basis of TASL recruitment by the peptide/histidine transporter 1, PHT1 2023 ·Nature Communications ·Tânia F. Custódio, (unknown), (unknown), (unknown), Daniel P. Teufel, Alexander Pautsch, Gisela Schnapp, Marc A. Grundl, Jan Kosiński, Christian Löw	10
2	Identification and Optimization of EphA2-Selective Bicycles for the Delivery of Cytotoxic Payloads 2020 ·Journal of Medicinal Chemistry ·Gemma Mudd, Amy Brown, Liuhong Chen, Katerine Van Rietschoten, (unknown), Daniel P. Teufel, Silvia Pavan, (unknown), Philip Huxley, Gavin Bennett	55
3	Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by Tumors 2019 ·Cancer Research ·Matthias Eder, Silvia Pavan, Ulrike Bauder‐Wüst, Katerine Van Rietschoten, (unknown), (unknown), (unknown), Catherine Stace, Edward H. Walker, Liuhong Chen, Gavin Bennett, Gemma Mudd, (unknown), Karin Leotta, Uwe Haberkorn, Klaus Kopka, Daniel P. Teufel	49
4	Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema 2018 ·Journal of Medicinal Chemistry ·Daniel P. Teufel, Gavin Bennett, (unknown), Katerine Van Rietschoten, Silvia Pavan, Catherine Stace, (unknown), Tine Van Bergen, (unknown), (unknown), Tjing‐Tjing Hu, Jean H.M. Feyen, Marc Vanhove	30
5	Development of BT1718, a Bicycle Drug Conjugate® (BDC) targeting MT1-MMP for treatment of solid tumours 2016 ·European Journal of Cancer ·Gavin Bennett, Hannah Harrison, S. Campbell, Daniel P. Teufel, G. Langford, April C. Watt, Christophe Bonny	14
6	Molecular Basis for Modulation of the p53 Target Selectivity by KLF4 2012 ·PLoS ONE ·Tobias Brandt, Fiona M. Townsley, Daniel P. Teufel, Stefan M.V. Freund, Dmitry B. Veprintsev	11
7	Bicyclic Peptides with Optimized Ring Size Inhibit Human Plasma Kallikrein and its Orthologues While Sparing Paralogous Proteases 2012 ·ChemMedChem ·Vanessa Baeriswyl, (unknown), (unknown), Catherine Stace, Daniel P. Teufel, Edward H. Walker, Shiyu Chen, Greg Winter, (unknown), Christian Heinis	60
8	Backbone-Driven Collapse in Unfolded Protein Chains 2011 ·Journal of Molecular Biology ·Daniel P. Teufel, C. Mark Johnson, (unknown), Hannes Neuweiler	91
9	Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73 2010 ·Oncogene ·(unknown), Tobias Brandt, Daniel P. Teufel, Dmitry B. Veprintsev, Andreas C. Joerger, Alan R. Fersht	46
10	S100 proteins interact with the N‐terminal domain of MDM2 2010 ·FEBS Letters ·(unknown), (unknown), Daniel P. Teufel, Alan R. Fersht	33
11	Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2 2009 ·Oncogene ·Daniel P. Teufel, Mark Bycroft, A.R. Fersht	119
12	Posttranslational Modifications Affect the Interaction of S100 Proteins with Tumor Suppressor p53 2009 ·Journal of Molecular Biology ·(unknown), Daniel P. Teufel, Agnès M. Jaulent, María Rosario Fernández‐Fernández, Trevor J. Rutherford, Aleksandra Wysłouch‐Cieszyńska, Alan R. Fersht	59
13	Interaction between the Transactivation Domain of p53 and PC4 Exemplifies Acidic Activation Domains as Single-stranded DNA Mimics 2009 ·Journal of Biological Chemistry ·S. Rajagopalan, Antonina Andreeva, Daniel P. Teufel, Stefan M.V. Freund, Alan R. Fersht	41
14	Molecular basis of the interactions between the p73 N terminus and p300: Effects on transactivation and modulation by phosphorylation 2009 ·Proceedings of the National Academy of Sciences ·Sarah Burge, Daniel P. Teufel, Fiona M. Townsley, Stefan M.V. Freund, Mark Bycroft, Alan R. Fersht	30
15	Downhill versus Barrier-Limited Folding of BBL 2: Mechanistic Insights from Kinetics of Folding Monitored by Independent Tryptophan Probes 2008 ·Journal of Molecular Biology ·Hannes Neuweiler, Timothy Sharpe, C. Mark Johnson, Daniel P. Teufel, Neil Ferguson, Alan R. Fersht	25
16	Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53 2007 ·Proceedings of the National Academy of Sciences ·Daniel P. Teufel, Stefan M.V. Freund, Mark Bycroft, Alan R. Fersht	165
17	Mutational Analysis of the Complex of Human RNase Inhibitor and Human Eosinophil-Derived Neurotoxin (RNase 2) 2003 ·Biochemistry ·Daniel P. Teufel, Richard Yi Tsun Kao, K. Ravi Acharya, Robert Shapiro	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact